^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | Jemperli (dostarlimab-gxly) (PD1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/10/2021
Excerpt:
Systemic therapy for advanced or metastatic disease...dostarlimab-gxly dosing
